Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angle Plc ADR (OP:ANPCY)

0.9912 UNCHANGED
Last Price Updated: 1:07 PM EDT, Apr 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.9912
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.9912
Today's Range 0.9912 - 0.9912
52wk Range 0.7362 - 3.350
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Angle PLC Announces Issue of LTIP Options and Share Options
Via ACCESS Newswire
Angle PLC Announces Results of Eisai Phase 2 pilot study
Via ACCESS Newswire

Performance

YTD
-26.6%
-26.6%
1 Month
-17.4%
-17.4%
3 Month
-49.0%
-49.0%
6 Month
-13.8%
-13.8%
1 Year
-58.7%
-58.7%

More News

Read More
Angle PLC Announces Analysis of CTC-DNA and ctDNA using Illumina assay
Via ACCESS Newswire
Angle PLC Announces Parsortix Used in Research Paper from ETH Zurich
Via ACCESS Newswire
Angle PLC Announces Trading Update
Via ACCESS Newswire
Angle PLC Announces HER2 Presentation at SABCS
Via ACCESSWIRE
Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR
Via ACCESSWIRE
Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR
Via ACCESSWIRE
Angle PLC Announces Parsortix enriched CTC & ctDNA in NSCLC patients
Via ACCESSWIRE
Angle PLC Announces 100th Publication Supporting Parsortix System Use
Via ACCESSWIRE
Angle PLC Announces Half-year Report
Via ACCESSWIRE
Angle PLC Announces Exclusive agreement for DNA NGS panel
Via ACCESSWIRE
Angle PLC Announces Agreement with Recursion Pharmaceuticals
Via ACCESSWIRE
Angle PLC Announces Notice of Interim Results and Webcast
Via ACCESSWIRE
Angle PLC - Data Supporting FDA Approval Published in Journal
Via ACCESSWIRE
Angle PLC Announces Standard Form for Notification of Major Holdings
Via ACCESSWIRE
Angle PLC Announces Standard Form for Notification of Major Holdings
Via ACCESSWIRE
Angle PLC Announces Result of 2024 Annual General Meeting
Via ACCESSWIRE
Angle PLC Announces Parsortix and Assays being Showcased at EACR 2024
Via ACCESSWIRE
Angle PLC Announces Study of Ovarian Cancer CTCs Using Parsortix
Via ACCESSWIRE
Angle PLC Announces New Commercial Agreement with Large Pharma
Via ACCESSWIRE
Angle PLC Announces Posting of 2023 Annual Report & Notice of the AGM
Via ACCESSWIRE
Angle PLC Announces New Commercial Agreement with AstraZeneca
Via ACCESSWIRE
Angle PLC Announces US and EU Patents for Innovative CellKeep(TM) Slide
Via ACCESSWIRE
Angle PLC Announces Parsortix HER2 Assay Showcased at AACR 2024
Via ACCESSWIRE

Frequently Asked Questions

Is Angle Plc ADR publicly traded?
Yes, Angle Plc ADR is publicly traded.
What exchange does Angle Plc ADR trade on?
Angle Plc ADR trades on the OTC Traded
What is the ticker symbol for Angle Plc ADR?
The ticker symbol for Angle Plc ADR is ANPCY on the OTC Traded
What is the current price of Angle Plc ADR?
The current price of Angle Plc ADR is 0.9912
When was Angle Plc ADR last traded?
The last trade of Angle Plc ADR was at 04/09/25 01:07 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.